| Revenue | 31/03/2019 | 31/03/2018 | 31/03/2017 | 31/03/2016 |
| Total revenue | 376,844,000 | 250,266,000 | 158,273,000 | 101,143,000 |
| Cost of revenue | 204,086,000 | 106,243,000 | 58,626,000 | 34,355,000 |
| Gross profit | 172,758,000 | 144,023,000 | 99,647,000 | 66,788,000 |
| Operating expenses |
| Research development | 37,435,000 | 22,754,000 | 17,060,000 | 13,788,000 |
| Selling general and administrative | 62,990,000 | 43,540,000 | 28,553,000 | 20,512,000 |
| Non-recurring | - | - | - | - |
| Others | - | - | - | - |
| Total operating expenses | 315,238,000 | 179,657,000 | 109,361,000 | 71,586,000 |
| Operating income or loss | 61,606,000 | 70,609,000 | 48,912,000 | 29,557,000 |
| Income from continuing operations |
| Total other income/expenses net | 35,181,000 | 9,002,000 | 6,090,000 | 50,181,000 |
| Earnings before interest and taxes | 61,606,000 | 70,609,000 | 48,912,000 | 29,557,000 |
| Interest expense | -5,190,000 | -3,566,000 | -2,671,000 | -1,946,000 |
| Income before tax | 96,787,000 | 79,611,000 | 55,002,000 | 79,738,000 |
| Income tax expense | 16,553,000 | 18,199,000 | 13,776,000 | 8,449,000 |
| Minority interest | 116,326,000 | 70,616,000 | 42,330,000 | 32,552,000 |
| Net income from continuing ops | 80,234,000 | 61,412,000 | 41,226,000 | 71,289,000 |
| Non-recurring events |
| Discontinued operations | - | - | - | - |
| Extraordinary items | - | - | - | - |
| Effect of accounting changes | - | - | - | - |
| Other items | - | - | - | - |
| Net income |
| Net income | 87,886,000 | 64,093,000 | 43,675,000 | 71,460,000 |
| Preferred stock and other adjustments | - | - | - | - |
| Net income applicable to common shares | 87,600,000 | 63,985,000 | 43,675,000 | 71,460,000 |